APOC3 and chronic kidney disease: Other studies have confirmed these results and provided evidence that the content of apoA-I and apoA-II of HDL was decreased [13,80], and the content of apoC-III and serum amyloid a (SAA) in HDL from CKD patients is increased [81,82,83].